BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 21087456)

  • 1. Localizing matrix metalloproteinase activities in the pericellular environment.
    Murphy G; Nagase H
    FEBS J; 2011 Jan; 278(1):2-15. PubMed ID: 21087456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
    Pohl M; Sakurai H; Bush KT; Nigam SK
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of MT-MMPs in embryonic development.
    Moracho N; Learte AIR; Muñoz-Sáez E; Marchena MA; Cid MA; Arroyo AG; Sánchez-Camacho C
    Dev Dyn; 2022 Feb; 251(2):240-275. PubMed ID: 34241926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing.
    McCarty SM; Cochrane CA; Clegg PD; Percival SL
    Wound Repair Regen; 2012; 20(2):125-36. PubMed ID: 22380687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules.
    Steffensen B; Häkkinen L; Larjava H
    Crit Rev Oral Biol Med; 2001; 12(5):373-98. PubMed ID: 12002821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
    Apte SS; Parks WC
    Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of human and mouse matrix metalloproteinase families.
    Jackson BC; Nebert DW; Vasiliou V
    Hum Genomics; 2010 Feb; 4(3):194-201. PubMed ID: 20368140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular regulation of metalloproteinases.
    Yamamoto K; Murphy G; Troeberg L
    Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases in renal development.
    Haas CS; Gleason B; Lin S; Tramonti G; Kanwar YS
    Connect Tissue Res; 2004; 45(2):73-85. PubMed ID: 15763922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases.
    Boyan BD; Schwartz Z
    Cells Tissues Organs; 2009; 189(1-4):70-4. PubMed ID: 18765931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases in lung diseases.
    Ohbayashi H
    Curr Protein Pept Sci; 2002 Aug; 3(4):409-21. PubMed ID: 12370004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.